Committed to improving the health of children, Dr. Arash Mahajerin is involved in numerous clinical research projects. He is the principal investigator of a research project involving thrombophilia testing in children and co-investigator of two research projects involving the incidence of VTE in children with elective neurosurgical procedures and assessing differences in fatigue experienced by patients undergoing proton beam therapy vs. conventional radiotherapy.
Dr. Mahajerin is board certified in Pediatrics and Pediatric Hematology/Oncology. Prior to joining CHOC Children’s, Dr. Mahajerin attended medical school at Michigan State University/College of Human Medicine. He performed his pediatric residency and conducted his fellowship training in pediatric hematology-oncology at Riley Hospital for Children/University of Indiana.
CHOC Children’s Clinic
1201 W. La Veta Ave. Building: CHOC Clinic
Orange, CA 92868
Dang Do A, Umoren R, Tarvin S, Heilbrunn B, Mahajerin A, Bowyer S. Systemic lupus erythematosus in a 3-month old male presenting as thrombocytopenia. Lupus. 2011:20(5);527-530.
Sharathkumar A, Mahajerin A, Heidt L, Doerfer K, Heiny M, Vik T, Fallon R, Rademaker A. Risk prediction tool for identifying hospitalized children with predisposition for development of VTE: Peds Clot Decision Rule (PCDR). J Thromb Haemost. 2012:10;1326-34.
Mahajerin A, Thornburg CD. Hospital-acquired venous thromboembolism in children: Call-to-Action. J Pediatr. 2014; 165(4):652-653.
Mahajerin A, Obasaju P, Eckert G, Vik TA, Mehta R, Heiny M. Thrombophilia testing in children: A 7 year experience. Pediatr Blood Cancer. 2014; 61(3):523-527.
Mahajerin A, Webber EC, Morris J, Taylor K, Saysana M. Development and implementation results of a venous thromboembolism (VTE) prophylaxis guideline in a tertiary care pediatric hospital. Hosp Pediatr. 2015; 5(12):630-6.
Buchbinder D, Hsieh L, Mahajerin A, Puthenveetil G, Soni A, Nugent D. Successful treatment of secondary graft failure following unrelated cord blood transplant with hematopoietic growth factors in a pediatric patient with Fanconi anemia. Pediatr Transplant. 2015; 19(7):E181-4.
Mahajerin A, Branchford BR, Amankwah E, Raffini L, Chalmers E, van Ommen CH, Goldenberg NA. Hospital-associated venous thromboembolism in pediatrics: a systematic review and meta-analysis of risk factors and risk assessment models. Haematologica. 2015; 100(8):1045-50.
Mahajerin A. Screening and prophylaxis for pediatric venous thrombus embolus (VTE) utilizing an automated decision support tool in the electronic medical record. Pediatric Hospital Medicine Annual Conference. 2014; Poster.
Mahajerin A. Children’s Hospital-Acquired Thrombosis Database (CHAT): A Multi-Institutional Database for Prospective Identification of Independent Risk Factors. American Society of Hematology 57th Annual Meeting. 2015; Poster.
Mahajerin A. Pediatric venous thromboembolism (VTE) screening tool: design, implementation, and continuous improvement of a complex clinical decision support tool. American Medical Informatics Association Annual Symposium. 2015; Poster.
Mahajerin A. Implementation of a pediatric venous thrombus embolus (VTE) tool in the electronic medical record (EMR) increases screening and may help decrease incidence of VTE. Pediatric Hospital Medicine. 2015; Poster.
Mahajerin A. Children’s Hospital-Acquired Thrombosis Database (CHAT): A Multi-Institutional for Prospective Identification of Independent Risk Factors. International Society of Thrombosis and Haemostasis 2015 Congress and 61st Annual SSC Meeting. 2015; Poster.
Mahajerin A. Pediatric Venous Thrombus Embolus (VTE): Utilization of Decision Support in the Electronic Medical Record for Screening and Prophylaxis. Pediatric Academic Societies. 2015; Poster.
Mahajerin A. Evaluation of Venous Thromboembolism Mechanical Prophylaxis Use in Pediatric Trauma Patients. Hemostasis and Thrombosis Research Society Scientific Symposium. 2015; Poster.
Mahajerin A. Children’s Hospital-Acquired Thrombosis Database (CHAT): A Multi-Institutional Database for Prospective Identification of Independent Risk Factors. Hemostasis and Thrombosis Research Society Scientific Symposium. 2015; Poster.
Thrombosis and Hemostasis Societies of North America 3rd Biennial Summit. 2016; Poster.